TY - JOUR
AU - Farzana, Refath
AU - Harbarth, Stephan Jürgen
AU - Yu, Ly-Mee
AU - Carretto, Edoardo
AU - Feasey, Nicholas Alexander
AU - Galal, Ushma
AU - Ergonul, Onder
AU - Yong, Dongeun
AU - Yusuf, Md Abdullah
AU - Veeraraghavan, Balaji
AU - Iregbu, Kenneth Chukwuemeka
AU - van Santen, James Anton
AU - Fankhauser, Carolina Maria
AU - Chilupsya, Chisomo Judith
AU - Dolecek, Christiane
AU - Ferreira, Diogo Boldim
AU - Pinarlik, Fatihan
AU - Jang, Jaehyeok
AU - Gücer, Lal Sude
AU - Cavazzuti, Laura
AU - Sultana, Marufa
AU - Haddad, Murielle Galas
AU - Medugu, Nubwa
AU - Nwajiobi-Princewill, Philip Ifeanyi
AU - Marrollo, Roberta
AU - Zhao, Rui
AU - Bakthavatchalam, Yamuna Devi
AU - COVID-19/DRI Study Group
AU - Moore, Catrin E.
AU - Gales, Ana C.
AU - da Silva Ribeiro, Aghata Cardoso
AU - Haque, M.D. Nazmul
AU - Baskaran, Vivekanandan B.
AU - Peter, John V.
AU - Chandy, Sujith J.
AU - Walsh, Timothy R.
PY - 2025
DA - March
TI - The impact of the COVID-19 pandemic on antimicrobial usage: an international patient-level cohort study
JO - JAC - Antimicrobial Resistance
VL - 7
IS - 2
DO - https://doi.org/10.1093/jacamr/dlaf037
AB - BackgroundThis study aimed to evaluate the trends in antimicrobial prescription during the first 1.5 years of COVID-19 pandemic.
PB - Oxford University Press
UR - https://hdl.handle.net/10023/32523
KW - Coronavirus (COVID-19)
ER